Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response of CHF 1535 (Foster) in Asthma
NCT01343745Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2008
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Feb 2008; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01343745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343745.